 |
Immune Globulins: Therapeutic, Pharmaceutical, Cost, and Administration Considerations
The most common question regarding immune globulin (Ig)
products relates to whether they are all the same. Even
though clinicians have considered all Ig products to be
clinically equivalent, they are not pharmaceutically equivalent.
JANUARY, 2010 |
 |
Guidelines for the Management of Febrile Neutropenia
For patients receiving chemotherapy, febrile
neutropenia often is associated with immediate
hospitalization and institution of empiric broadspectrum
antibiotic therapy. Although the condition remains
a major source of morbidity and mortality, improvements
in treatment have significantly improved outcomes.
DECEMBER, 2009 |
 |
Contemporary Management Of Hyponatremia
Hyponatremia, a common electrolyte imbalance, generally
is defined as a serum sodium concentration of less than
135 mEq/L. Patients with acute or moderate to severe
hyponatremia may present with neurologic signs and symptoms
and may be at risk for long-term complications. However, even
patients with mild, chronic forms of the disorder may be at risk for
significant morbidity, making recognition and appropriate treatment
essential.
NOVEMBER, 2009 |
 |
Present and Future Management Options for Clostridium difficile Infection
Treatment selection for Clostridium difficile infection (CDI) has become more
complex despite the lack of new FDA-approved treatments. The challenge
of managing these patients is due, in part, to the growing prevalence and
severity of the disease. Fortunately, algorithms based on the severity of illness
can help clinicians choose among currently available medications. And several
investigational agents show promise for reducing the high rate of CDI recurrence.
OCTOBER, 2009 |
 |
Immune Globulins: Therapeutic, Pharmaceutical, Cost, and Administration Considerations
The most common question regarding immune globulin (Ig)
products relates to whether they are all the same. Even
though clinicians have considered all Ig products to be
clinically equivalent, they are not pharmaceutically equivalent.
OCTOBER, 2009 |
 |
Guidelines for the Prevention Of Medication Errors
The prevention of medication errors
is an essential requirement for
pharmaceutical care and must be a
core mission of every pharmacy. If efforts
to prevent medication errors are to be
effective and successful, they must
become a priority.
OCTOBER, 2009 |
 |
Treatment of Nausea and Vomiting In the Oncology Setting
The American Society of Clinical Oncology,1 the European
Society of Medical Oncology,2 the Multinational Association of
Supportive Care in Cancer,3 and the National Comprehensive
Cancer Network4 have all recently published antiemetic guidelines.
OCTOBER, 2009 |
 |
Assessment Tools and Guidelines: Parenteral Nutrition Therapy
Malnutrition is associated
with an increased
frequency of treatment
complications and length of stay in the intensive care unit (ICU) and hospital,
as well as increased costs of medical care. Patients at high risk for malnutrition
should be identified and evaluated for specialized nutrition support (SNS).
OCTOBER, 2009 |
|